Delivery Order SPE2DP20D0002-SPE2DP21F0134
- Not listed
- The Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. The $135,747.00 contract has an October 27, 2020 completion date and was awarded on October 19, 2020. Teva has previously received similar delivery orders from the Defense Logistics Agency to support military immunization programs. The company also holds active indefinite...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price Delivery Order contract to Teva Pharmaceuticals USA, Inc. for the delivery of Adenovirus Type 4 vaccines. The $135,747.00 contract has an August 25, 2020 completion date. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit manufacturer that has provided a range of pharmaceutical products, including vaccines, antiviral medications, and respiratory treatments, to federal customers such as the Department of...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide adenovirus type 4 vaccine. The $146,823.93 order is not set aside and has a completion date of July 26, 2022. Teva has previously received numerous delivery orders from the Defense Logistics Agency to supply adenovirus vaccines and other pharmaceutical products such as albuterol inhalers to federal...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a $146,823.93 firm fixed price delivery order to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, to provide adenovirus type 4 vaccine. This order supports military immunization programs. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that manufactures a range of drug products, including vaccines, antivirals, respiratory treatments, and multiple sclerosis medications for federal customers...
- The U.S. Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $141,176.88 firm fixed-price delivery order to provide Adenovirus Type 4 vaccine. This order was not set aside under any special socioeconomic program. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit pharmaceutical manufacturer that has an extensive history of providing drug products, including vaccines and respiratory medications, to federal agencies such as the Department of Defense...
- The Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. The $135,747 order has an October 27, 2020 completion date and was awarded on October 19, 2020. Teva Pharmaceuticals USA, Inc. has provided various drug products, including vaccines, to federal agencies such as the Department of Defense and Department of Veterans Affairs. While...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $317,609.46 firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Teva with DLA Troop Support Medical for providing critical pharmaceuticals to support military immunization programs. Teva has also been awarded other significant...
- The Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. The $407,241.00 order has a completion date of July 28, 2020. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that delivers patient-centric healthcare solutions, including vaccines, antiviral medications, and respiratory treatments, to federal customers such as the Department...
- The Defense Logistics Agency Troop Support Medical awarded a firm-fixed price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit manufacturer, to provide Adenovirus Type 4 vaccines. The $141,176.88 contract has a completion date of September 28, 2021 and does not include any set-aside designations. Teva has provided various pharmaceutical products, including vaccines, antivirals, respiratory treatments, and multiple sclerosis drugs, to federal customers such as the...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $476,414.19 firm fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccines. This contract, which has a completion date of May 21, 2024, supports military immunization programs. Teva Pharmaceuticals USA, Inc. has a long history of supplying critical pharmaceuticals, including other vaccines and medications, to various federal...
- SPE2DP20D0002Indefinite Delivery Contract
- SPE2DP20D0002-SPE2DP21F0134Delivery Order
The Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit manufacturer, to provide Adenovirus Type 4 vaccine. The $135,747.00 award has an October 27, 2020 completion date and was issued on October 19, 2020. This delivery order supports military immunization programs. Teva Pharmaceuticals USA, Inc. holds multiple indefinite delivery contracts with federal agencies, including a 5-year IDIQ with the VA National Acquisition Center worth up to $109 million to supply Albuterol HFA inhalers with dose counters. The company has a history of providing pharmaceutical products like vaccines, antivirals, and respiratory treatments to government customers.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
ADENOVIRUS TYPE 4 A | SPE2DP18R01130009 | Defense Logistics Agency Troop Support Medical | Award Notice 1/1 | 2/3/20, 2:02 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $135.7k | 10/19/20 |